| | | | | | | | |
Name | | Jurisdiction of Incorporation |
Allergan Ligand Retinoid Therapeutics, Inc. | | Delaware |
Aramed Inc. | | Delaware |
Cita NeuroPharmaceuticals Inc. | | Canada |
CyDex Pharmaceuticals, Inc. | | Delaware |
Glycomed Incorporated | | California |
Ligand Biopharmaceuticals Incorporated | | Delaware |
Ligand Holdings UK Limited | | England and Wales |
Ligand JVR, Inc. | | Delaware |
Ligand Pharmaceuticals (Canada) Incorporated | | Canada |
Ligand Pharmaceuticals International, Inc. | | Delaware |
Ligand Pharmaceuticals UK Limited | | United Kingdom |
Ligand UK Development Limited | | England and Wales |
Ligand UK Group Limited | | England and Wales |
Ligand UK Limited | | England and Wales |
Ligand UK Research Limited | | England and Wales |
Metabasis Therapeutics, Inc. | | Delaware |
Neurogen Corporation | | Delaware |
Pfenex Inc. | | Delaware |
Pharmacopeia, LLC | | Delaware |
Seragen Incorporated | | Delaware |
Seragen Technology, Inc. | | Delaware |
Vernalis Therapeutics Inc. | | Delaware |
Verrow Pharmaceuticals | | Kansas |